Jazz Pharmaceuticals: brands it owns and its ownership tree
Jazz Pharmaceuticals (NASDAQ: JAZZ) is a publicly listed company headquartered in Dublin, Ireland that owns 2 consumer brands.[1]
Jazz Pharmaceuticals is an Irish-domiciled biopharmaceutical company based in Dublin. Its 2025 Form 10-K reports sales of sleep, epilepsy and oncology medicines.
-
brands owned
-
1
categories
-
0
acquisitions recorded
-
0
divestitures recorded
Company facts
- Legal name
- Jazz Pharmaceuticals plc
- Type
- publicly listed company · see all publicly listed company owners
- Headquarters
- 🇮🇪 Dublin, Ireland
- Founded
- 2003
- Tickers
- NASDAQ: JAZZ
- SEC CIK
- 0001232524
- Last verified
- · 1 sources
Jazz Pharmaceuticals in numbers
- Jazz Pharmaceuticals owns 2 consumer brands tracked here across 1 top-level categories; the largest is healthcare & pharma with 2 brands.[1]
Jazz Pharmaceuticals financial history
Headline figures from Jazz Pharmaceuticals's annual reports filed with the US Securities and Exchange Commission, in USD as reported, fiscal years ending 2020–2025. Revenue moved from $2.36bn to $4.27bn, an average of 12.5% a year (calculated).
| Fiscal year ended | Revenue | Operating income | Operating margin | Net income | Total assets | Long-term debt | Filing |
|---|---|---|---|---|---|---|---|
| $4.27bn | $-430,240,000 | -10.1% | $-356,148,000 | $11.7bn | $4.33bn | 10-K | |
| $4.07bn | $716.6m | 17.6% | $560.1m | $12bn | $6.08bn | 10-K | |
| $3.83bn | $578.6m | 15.1% | $414.8m | $11.4bn | $5.11bn | 10-K | |
| $3.66bn | $-65,528,000 | -1.8% | $-224,060,000 | $10.8bn | $5.69bn | 10-K | |
| $3.09bn | $170.3m | 5.5% | $-329,668,000 | $12.3bn | $6.02bn | 10-K | |
| $2.36bn | $378.1m | 16.0% | $238.6m | $6.54bn | $1.85bn | 10-K |
Source: SEC XBRL company facts. A dash means the company did not report that line in a form we could read. Figures for a year can be restated in a later filing; the latest filing's number is shown.
Everything Jazz Pharmaceuticals owns
Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.
Full-screen interactive tree →
Brand portfolio by category
Recent changes to this record
Jazz Pharmaceuticals SEC filings
The documents behind the figures on this page, as listed in the SEC's EDGAR index. Each links to the filing itself.
Annual reports
- Annual report (amended), filed (10-K/A)
- Annual report, filed (10-K)
- Annual report (amended), filed (10-K/A)
- Annual report, filed (10-K)
- Annual report (amended), filed (10-K/A)
- Annual report, filed (10-K)
- Annual report (amended), filed (10-K/A)
- Annual report, filed (10-K)
- Annual report (amended), filed (10-K/A)
- Annual report, filed (10-K)
- Annual report (amended), filed (10-K/A)
- Annual report, filed (10-K)
Proxy statements
- Proxy statement, filed (DEF 14A)
- Proxy statement, filed (DEF 14A)
- Proxy statement, filed (DEF 14A)
Recent current and quarterly reports
| Filed | Form | What it declares |
|---|---|---|
| 8-K | Departure or appointment of directors or officers | |
| 8-K | Entry into a material agreement; Creation of a direct financial obligation | |
| 8-K | Regulation FD disclosure | |
| 8-K | Entry into a material agreement; Creation of a direct financial obligation; Unregistered sales of equity securities; Other events | |
| 8-K | Other events | |
| 8-K | Entry into a material agreement | |
| 8-K | Regulation FD disclosure | |
| 10-Q | Quarterly report | |
| 8-K | Results of operations and financial condition | |
| 8-K | Results of a shareholder vote | |
| 8-K | Departure or appointment of directors or officers | |
| 10-Q | Quarterly report | |
| 8-K | Results of operations and financial condition | |
| 8-K | Results of operations and financial condition |
Frequently asked questions
What brands does Jazz Pharmaceuticals own?
Jazz Pharmaceuticals owns 2 consumer brands tracked here, including Rylaze and Xywav.
Is Jazz Pharmaceuticals an Irish company?
Yes. Jazz Pharmaceuticals is headquartered in Dublin, Ireland and was founded in 2003.
Who owns Jazz Pharmaceuticals?
Jazz Pharmaceuticals is a publicly listed company owned by its shareholders; it trades as JAZZ on the NASDAQ.
Sources (1) & corrections
Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.
- [1] Jazz Pharmaceuticals plc Annual Report on Form 10-K filed 2026-02-24 — SEC EDGAR, SEC Form 10-K, published 24 February 2026; retrieved 18 October 2026.
Report a correction Opens a pre-filled GitHub issue. See our corrections policy.